Ignazio Geraci is a Senior Scientist in Gene Editing at Bayer since 2022. They completed a PhD in Molecular Biomedicine at the University of Bonn in 2021, following a Master’s degree in Applied Science from Università degli Studi di Palermo. Previously, Ignazio gained significant research experience through roles at Roche, Novartis Vaccines & Diagnostics, and the Babraham Institute, among others, focusing on RNA technologies and protein biochemistry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices